Variable | Male | Female | ||
---|---|---|---|---|
Control | CHD | Control | CHD | |
(n=99) | (n=176) | (n=91) | (n=70) | |
Age (year) | 52.5±9.2 | 61.0±10.7 | 51.0±7.4 | 61.8±10.6 |
UA (µmol/L) | 395.3±80.3 | 363.4±97.9 | 297.0±74.3 | 298.5±88.4 |
TC (mmol/L) | 4.7±0.8 | 4.5±1.1 | 4.7±0.7 | 4.62±1.2 |
TG (mmol/L) | 1.8 (1.2, 2.6) | 1.7 (1.3, 2.4) | 1.3 (1.0, 2.0) | 1.8 (1.4, 2.9) |
HDL-C (mmol/L) | 1.4±0.3 | 1.2±0.2 | 1.6±0.3 | 1.3±0.3 |
LDL-C (mmol/L) | 2.9±0.8 | 2.5±0.9 | 2.9±0.6 | 2.6±0.9 |
apoA (g/L) | 1.5±0.2 | 1.3±0.2 | 1.7±0.2 | 1.5±0.3 |
apoB (g/L) | 0.99±0.24 | 1±0.23 | 0.93±0.2 | 0.97±0.29 |
Lp(a) (mg/L) | 188.0 (85.0, 373.0) | 297.0 (140.0, 433.0) | 163.0 (81.0, 327.0) | 248.0 (98.0, 470.0) |
HCY (µmol/L) | 10.3 (8.5, 12.8) | 14.5 (11.9, 19.0) | 6.4 (5.3, 7.8) | 11.6 (9.0, 13.7) |
TBil (µmol/L) | 13.4 (10.7, 16.5) | 14.2 (11.2, 19.3) | 10.8 (8.7, 13.1) | 12.8 (10.4, 17.7) |
Dbil (µmol/L) | 3.0 (2.5, 3.8) | 3.0 (1.9, 4.3) | 2.3 (1.9, 2.9) | 2.2 (1.5, 3.2) |
IBil (µmol/L) | 10.4 (8.1, 13.1) | 11.0 (8.5, 15.2) | 8.3 (6.5, 10.4) | 11.2 (8.4, 14.2) |
GGT (IU/L) | 27.0 (17.0, 47.0) | 35.0 (22.0, 79.0) | 18.0 (12.0, 25.0) | 25.0 (16.0, 44.0) |
Normally distributed data were presented as means±SD, skewed data were presented as the median (IQR).
apoA, apolipoprotein A; apoB, apolipoprotein B; Bil, indirect bilirubin; CHD, coronary heart disease; DBil, direct bilirubin; GGT, γ-glutamyl transpeptidase; HCY, homocysteine; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); TBil, total bilirubin; TC, total cholesterol; TG, triglyceride; UA, uric acid.